Infliximab, an anti-TNF-alpha agent, improves left atrial abnormalities in patients with rheumatoid arthritis: preliminary results

BACKGROUND: Rheumatoid arthritis (RA) is associated with increased cardiovascular morbidity and mortality. In the current prospective study, we addressed the impact of RA on left atrial (LA) function and electrical remodelling. Further, we tried to demonstrate the effects of infliximab, an anti-TNFa...

Descripción completa

Detalles Bibliográficos
Autores principales: Süha, Çetin, Mustafa Gökhan, Vural, Ekrem, Yeter, Mehmet, Doğan, Göksal, Keskin, Mehmet Akif, Öztürk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Clinics Cardive Publishing 2014
Materias:
Cardiovascular Topics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170177/
https://www.ncbi.nlm.nih.gov/pubmed/25192300
http://dx.doi.org/10.5830/CVJA-2014-036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170177/
https://www.ncbi.nlm.nih.gov/pubmed/25192300
http://dx.doi.org/10.5830/CVJA-2014-036

Ejemplares similares